Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 30.40
+0.20 (0.66%)
Jan 9, 2026, 1:35 PM CST
Polaris Group Company Description
Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services.
The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications, as well as provides healthcare consulting, staffing, and MDS solutions.
The company was incorporated in 2006 and is based in Grand Cayman, Grand Cayman.
Polaris Group
| Country | Cayman Islands |
| Founded | 2006 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 165 |
| CEO | Shyan Chen |
Contact Details
Address: PO Box 309 Grand Cayman, KY1-1104 Cayman Islands | |
| Phone | 813 886 6500 |
| Website | polaris-group.com |
Stock Details
| Ticker Symbol | 6550 |
| Exchange | Taiwan Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | KYG7171A1085 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jack Fitzgibbons | President and Chief Operating Officer |
| Ray Wu M.B.A. | Chief Financial Officer |
| Yimingli Gao | Accounting Supervisor |
| Chien-Hsing Chang | Chief Strategy Officer |
| Kevin Wu | Chief Information Security Officer |
| Yuexun Wu | Deputy General Manager |